Search

Your search keyword '"Loftis, Jennifer"' showing total 179 results

Search Constraints

Start Over You searched for: Author "Loftis, Jennifer" Remove constraint Author: "Loftis, Jennifer"
179 results on '"Loftis, Jennifer"'

Search Results

151. Yoga vs Cognitive Processing Therapy for Military Sexual Trauma-Related Posttraumatic Stress Disorder: A Randomized Clinical Trial.

152. Immunotherapeutic treatment of inflammation in mice exposed to methamphetamine.

153. Inflammatory and mental health sequelae of COVID-19.

154. Cognitive impairment in long-COVID and its association with persistent dysregulation in inflammatory markers.

155. Differences in rates of impairment in adults who use methamphetamine using two sets of demographically corrected norms.

156. The association between heightened ADHD symptoms and cytokine and fatty acid concentrations during pregnancy.

158. Synchronous Telehealth Yoga and Cognitive Processing Group Therapies for Women Veterans with Posttraumatic Stress Disorder: A Multisite Randomized Controlled Trial Adapted for COVID-19.

160. Cognition during active methamphetamine use versus remission.

161. Yoga for veterans with PTSD: Cognitive functioning, mental health, and salivary cortisol.

162. Evaluation of maternal inflammation as a marker of future offspring ADHD symptoms: A prospective investigation.

163. Partial MHC/neuroantigen peptide constructs attenuate methamphetamine-seeking and brain chemokine (C-C motif) ligand 2 levels in rats.

165. Neuroimmune basis of methamphetamine toxicity.

166. Vulnerability to somatic symptoms of depression during interferon-alpha therapy for hepatitis C: a 16-week prospective study.

167. Social housing and alcohol drinking in male-female pairs of prairie voles (Microtus ochrogaster).

168. Methamphetamine causes persistent immune dysregulation: a cross-species, translational report.

169. Prophylactic antidepressant treatment in patients with hepatitis C on antiviral therapy: a double-blind, placebo-controlled trial.

170. Serum Serotonin Levels are Associated with Antiviral Therapy Outcomes in Patients with Chronic Hepatitis C.

171. Antiviral completion rates and sustained viral response in hepatitis C patients with and without preexisting major depressive disorder.

172. Depressive symptoms in patients with chronic hepatitis C are correlated with elevated plasma levels of interleukin-1beta and tumor necrosis factor-alpha.

173. A randomized trial of paroxetine to prevent interferon-alpha-induced depression in patients with hepatitis C.

174. Interferon alpha therapy for hepatitis C: treatment completion and response rates among patients with substance use disorders.

175. Administration of pegylated interferon-alpha-2a or -2b does not induce sickness behavior in Lewis rats.

177. Serotonin a la carte: supplementation with the serotonin precursor 5-hydroxytryptophan.

178. The association between viral clearance and depression in patients with hepatitis C receiving interferon-alpha and ribavirin.

179. Association of interferon-alpha-induced depression and improved treatment response in patients with hepatitis C.

Catalog

Books, media, physical & digital resources